Roger Green serves as CEO at RG+A, Inc., Managing Principal of Hep Dynamics LLC and Managing Director of Go To Market Advisors, LLC.
RG+A, founded in 1991, provides Market Research, forecasting and strategic support services to biopharmaceutical, medical device and diagnostics companies. In recent years, RG+A has worked with translational diagnostics companies and digital AI firms on market development and education.
Hep Dynamics, founded in 2020, provides strategic support on commercialization issues for drug and diagnostics companies in the liver and rare disease markets. Hep Dynamics specializes in devising innovative strategies to identify the niches and messages that maximize opportunities for developmental products and helping clients identify key activities to realize these opportunities. Also, Hep Dynamics sponsors Surfing the NASH Tsunami, a weekly podcast in which a panel of experts discusses commercial developments and challenges in the global NASH market.
Go To Market Advisors is a consultancy led by Mr. Green and Dr. Stephen Harrison to work with pre-market liver disease companies in developing core strategy, clinical and commercial development plans and business plans before introducing them to possible funding sources.
Mr. Green speaks regularly on behalf of investment firms, Market Research industry organizations and disease advocacy groups, most recently including the 2020 NASH-TAG and Bio CEO conferences. His work has been published in academic and industry publications. He is a former President of the Pharmaceutical Marketing Research Group, now part of Intellus Worldwide, and the 2008 recipient of the R.R. Fordyce Award, an honor bestowed upon leaders in the marketing research industry dedicated to the betterment of the profession.
Mr. Green received a BA in political science and an MBA in marketing from Columbia University.
